Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Prostaglandin F2alpha antagonist THG-113.31 delays preterm birth in sheep

Sep. 20, 2005

Cholesterol absorption inhibitor MD-0727 enters phase I testing

Sep. 20, 2005

Pharmacokinetics of oral insulin analogue IN-105 resemble those of insulin

Sep. 20, 2005

Antidiabetic potential of RWJ-348260 evident in preclinical models

Sep. 20, 2005

New data on the effects of DiaPep277 in patients with type 1 diabetes

Sep. 19, 2005

Once-monthly Bonviva approved in E.U. for postmenopausal osteoporosis

Sep. 19, 2005

Myozyme studied for late-onset Pompe disease

Sep. 19, 2005

Rosiglitazone improves treatment satisfaction in elderly patients with type 2 diabetes

Sep. 19, 2005

A-761: Novel MCHR1 antagonist with in vivo efficacy and cardiovascular safety

Sep. 19, 2005

FDA expands Neulasta label

Sep. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...